UNITY presents 12-week data from phase II study of UBX-0101 in painful osteoarthritis of the knee Aug. 18, 2020 No Comments
Dosing initiates in phase Ib study of plonmarlimab in Chinese patients with RA Aug. 18, 2020 No Comments
Fulcrum looks for balance in its phase II FSHD study Aug. 11, 2020 By Lee Landenberger No Comments An interim analysis from Fulcrum Therapeutics Inc.’s phase II study of losmapimod for treating facioscapulohumeral muscular dystrophy (FSHD) produced data that pleased the CEO and displeased investors.Read More
Sareum reports findings with TYK2/JAK1 inhibitors in disease model of lupus July 24, 2020 No Comments
NMD Pharma cleared to begin phase I/IIa trial of NMD-670 for myasthenia gravis July 15, 2020 No Comments
RSS
